SOLECROSS

Large database analysis examining niacinamide's potential role in skin cancer prevention through supplementation.

Not specified in abstract provided Journal of the American Academy of Dermatology. 2026. PubMed →

Research indicates that neutral pH (7.4) formulations increase niacinamide skin permeation approximately twofold compared to acidic pH (5.0), with corresponding changes in stratum corneum electrical properties facilitating enhanced transdermal delivery. Studies employed Franz cell diffusion experiments and electrical impedance spectroscopy using human skin models to characterize pH-dependent permeation mechanisms.

Not specified in abstract provided Scientific Reports. 2026. PubMed →

Research indicates that dissolving microneedle patches containing niacinamide exhibit greater skin-lightening effects than traditional topical formulations for treating melasma and post-inflammatory hyperpigmentation. Clinical studies have validated safety and efficacy with minimal adverse effects when using advanced transdermal delivery systems.

Not specified in abstract provided Recent Advances in Drug Delivery and Formulation. 2026. PubMed →

Systematic umbrella review evaluating nutritional supplements including niacinamide for primary prevention of skin diseases across 9,229 participants, examining preventive effects against ultraviolet radiation-induced skin pathology and other dermatological conditions.

Not specified in abstract provided Preventive Nutrition and Food Science. 2026. PubMed →

Research comparing glabridin with niacinamide as recognized inhibitor of melanosome transfer in UVB-irradiated co-culture systems demonstrated complementary mechanisms for reducing melanin transfer from melanocytes to keratinocytes through dendrite suppression pathways.

Not specified in abstract provided Pharmaceuticals (Basel, Switzerland). 2026. PubMed →